从不吸烟者的慢性阻塞性肺疾病:危险因素、发病机制及防治意义
本文综述从不吸烟者中慢性阻塞性肺疾病(COPD)的疾病负担、危险因素、临床表现与发病机制。全球约半数COPD病例由非烟草相关危险因素所致,且因地理区域而异。与吸烟所致COPD相比,从不吸烟者COPD症状较轻、肺气肿少、气流受限轻、合并症少,但仍可频繁急性加重。
要点
- 全球约半数COPD病例由非烟草相关危险因素所致,危险因素因地理区域而异。
- 从不吸烟者COPD的潜在危险因素包括空气污染、职业暴露、哮喘控制不佳、环境烟草烟雾、感染性疾病及低社会经济地位。
- 与吸烟所致COPD相比,从不吸烟者COPD症状较轻、肺气肿少、气流受限轻、合并症少,但仍可频繁急性加重。
核心结论
- 全球约半数COPD病例由非烟草相关危险因素所致,从不吸烟者COPD的疾病负担、危险因素和临床表型需进一步研究以减少其负担。
研究设计与样本
- 本文为综述,汇总关于从不吸烟者COPD的疾病负担、危险因素、发病机制和临床表现的现有证据。
主要发现
- 全球约半数COPD病例由非烟草相关危险因素所致,这些因素因地理区域而异。
- 从不吸烟者COPD的危险因素包括空气污染、职业暴露、哮喘控制不佳、环境烟草烟雾、感染性疾病及低社会经济地位。
- 儿童期肺生长受损(由一系列早期生活暴露引起)与COPD风险增加相关。
- 从不吸烟者COPD的潜在发病机制包括炎症、氧化应激、气道重塑和加速的肺老化。
- 与吸烟所致COPD相比,从不吸烟者COPD慢性呼吸道症状相对较轻、肺气肿很少或无、气流受限较轻、合并症较少,但急性加重仍可频繁发生。
局限性
- 原文指出需进一步开展流行病学、转化、临床和实施研究以填补理解空白并推进减少从不吸烟者COPD负担的潜在解决方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic obstructive pulmonary disease (COPD) was traditionally thought to be caused by tobacco smoking. However, recognition of the importance of non-smoking-related risk factors for COPD has increased over the past decade, with evidence on the burden, risk factors, and clinical presentations of COPD in never-smokers. About half of all COPD cases worldwide are due to non-tobacco-related risk factors, which vary by geographical region. These factors include air pollution, occupational exposures, poorly controlled asthma, environmental tobacco smoke, infectious diseases, and low socioeconomic status. Impaired lung growth during childhood, caused by a range of early-life exposures, is associated with an increased risk of COPD. Potential mechanisms for the pathogenesis of COPD in never-smokers include inflammation, oxidative stress, airway remodelling, and accelerated lung ageing. Compared with smokers who develop COPD, never-smokers with COPD have relatively mild chronic respiratory symptoms, little or no emphysema, milder airflow limitation, and fewer comorbidities; however, exacerbations can still be frequent. Further research-including epidemiological, translational, clinical, and implementation studies-is needed to address gaps in understanding and to advance potential solutions to reduce the burden of COPD in never-smokers.
引用
- Yang IA, Jenkins CR, Salvi SS, et al. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022. PMID: 35427530. doi:10.1016/S2213-2600(21)00506-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。